(Q46404003)

English

Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/16433895

Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/16433895

stereoselectivity

1 reference

based on heuristic

inferred from title

Piero Pollesello

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/16433895

author name string

Petri Kaheinen

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/16433895

Zita Hertelendi

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/16433895

Attila Borbély

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/16433895

Szabolcs Szilágyi

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/16433895

Erkki Nissinen

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/16433895

Heimo Haikala

7

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/16433895

Zoltán Papp

8

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/16433895

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/16433895

Basic and Clinical Pharmacology and Toxicology

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/16433895

98

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/16433895

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/16433895

74-78

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/16433895

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_231.X

21 January 2018

The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_231.X

21 January 2018

Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_231.X

21 January 2018

Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_231.X

21 January 2018

The effects of levosimendan on [Ca2+]i in guinea-pig isolated ventricular myocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_231.X

21 January 2018

Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: structure-response and binding analysis with analogs of levosimendan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_231.X

21 January 2018

The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_231.X

21 January 2018

Binding of levosimendan, a calcium sensitizer, to cardiac troponin C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_231.X

21 January 2018

Interaction of levosimendan with cardiac troponin C in the presence of cardiac troponin I peptides

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_231.X

21 January 2018

Stereoselective binding of levosimendan to cardiac troponin C causes Ca2+-sensitization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_231.X

21 January 2018

The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_231.X

21 January 2018

Identifiers

10.1111/J.1742-7843.2006.PTO_231.X

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/16433895

release_fk6dqrbxzff3nk7a5thz3eeeta

1 reference

https://api.fatcat.wiki/v0/release/fk6dqrbxzff3nk7a5thz3eeeta

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/16433895

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46404003&oldid=2109696699"